Your browser doesn't support javascript.
loading
Assessing the value of mepolizumab for severe eosinophilic asthma: a cost-effectiveness analysis.
Whittington, Melanie D; McQueen, R Brett; Ollendorf, Daniel A; Tice, Jeffrey A; Chapman, Richard H; Pearson, Steven D; Campbell, Jonathan D.
Afiliação
  • Whittington MD; Department of Clinical Pharmacy, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • McQueen RB; Department of Clinical Pharmacy, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Ollendorf DA; Institute for Clinical and Economic Review, Boston, Massachusetts.
  • Tice JA; Department of Medicine, University of California-San Francisco, San Francisco, California.
  • Chapman RH; Institute for Clinical and Economic Review, Boston, Massachusetts.
  • Pearson SD; Institute for Clinical and Economic Review, Boston, Massachusetts.
  • Campbell JD; Department of Clinical Pharmacy, University of Colorado Anschutz Medical Campus, Aurora, Colorado. Electronic address: Jon.Campbell@UCDenver.edu.
Ann Allergy Asthma Immunol ; 118(2): 220-225, 2017 Feb.
Article em En | MEDLINE | ID: mdl-27923549

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Antiasmáticos / Eosinófilos / Anticorpos Monoclonais Humanizados Tipo de estudo: Health_economic_evaluation / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Allergy Asthma Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Antiasmáticos / Eosinófilos / Anticorpos Monoclonais Humanizados Tipo de estudo: Health_economic_evaluation / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Allergy Asthma Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2017 Tipo de documento: Article